Clinical Trial Update: Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis

View source ↗

Summary

This update reports the completion of an Optical Coherence Tomography (OCT) trial in patients with Relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis, RRMS | Status: COMPLETED